高级检索
当前位置: 首页 > 详情页

RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Zhujiang Hospital, Southern Medical University, Guangzhou, China [2]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China [3]Integrated Hospital of Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, Guangdong, China [4]Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China [5]Shenzhen Hospital, University of Chinese Academy of Sciences, Shenzhen, Guangdong, China
出处:
ISSN:

关键词: RAGE Iron metabolism Macrophages Oxidative stress Lipid peroxidation Inflammation

摘要:
Alcoholic liver disease (ALD) is associated with hepatic inflammatory activation and iron overload. The receptor for advanced glycation end products (RAGE) is an important metabolic mediator during the development of ALD. The aim of this study was to determine the effect of RAGE on iron homeostasis in ALD. We found increased circulating transferrin, hepcidin and ferritin in ALD patients and positively correlated with RAGE level. RAGE knockout (RAGE-/-) and wild-type mice were subjected to chronic alcoholic feeding for 6 weeks to induce ALD, and RAGE inhibitor, iron chelator or lipid peroxidation inhibitor were administered. We showed that chronic alcohol administration triggered hepatic steatosis, inflammation, and oxidative stress, which were eliminated by deficiency or inhibition of RAGE. Surprisingly, pathways of hepatic iron metabolism were significantly altered, including increased iron uptake (Tf/TfR) and storage (Ferritin), as well as decreased iron export (FPN1/Hepcidin). In vitro experiments confirmed that RAGE had different effects on the mechanism of iron metabolism of hepatocytes and macrophages respectively. In conclusion, our data revealed preclinical evidence for RAGE inhibition as an effective intervention for alleviating alcohol-induced liver injury.Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 生物学
小类 | 1 区 生化与分子生物学
最新[2025]版:
大类 | 1 区 生物学
小类 | 1 区 生化与分子生物学
JCR分区:
出版当年[2021]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Zhujiang Hospital, Southern Medical University, Guangzhou, China [2]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China
共同第一作者:
通讯作者:
通讯机构: [1]Zhujiang Hospital, Southern Medical University, Guangzhou, China [2]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China [3]Integrated Hospital of Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, Guangdong, China [*1]Zhujiang Hospital and School of Traditional Chinese Medicine, Southern Medical University (SMU), Sha Tai Nan Road No. 1063, Guangzhou, Guangdong, 510515, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号